Literature DB >> 22325011

Critical immune and vaccination thresholds for determining multiple influenza epidemic waves.

Laura Matrajt1, Ira M Longini.   

Abstract

Previous influenza pandemics (1918, 1957, and 1968) have all had multiple waves. The 2009 pandemic influenza A (H1N1) (pandemic H1N1) started in April 2009 and was followed, in the United States (US) and temperate Northern Hemisphere, by a second wave during the fall of 2009. The ratio of susceptible and immune individuals in a population at the end of a wave determines the potential and magnitude of a subsequent wave. As influenza vaccines are not completely protective, there was a combined immunity in the population at the beginning of 2010 (due to vaccination and due to previous natural infection), and it was uncertain if this mixture of herd immunity was enough to prevent a third wave of pandemic influenza during the winter of 2010. Motivated by this problem, we developed a mathematical deterministic two-group epidemic model with vaccination and calibrated it for the 2009 pandemic H1N1. Then, applying methods from mathematical epidemiology we developed a scheme that allowed us to determine critical thresholds for vaccine-induced and natural immunity that would prevent the spread of influenza. Finally, we estimated the level of combined immunity in the US during winter 2010. Our results suggest that a third wave was unlikely if the basic reproduction number R(0) were below 1.6, plausible if the original R(0) was 1.6, and likely if the original R(0) was 1.8 or higher. Given that the estimates for the basic reproduction number for pandemic influenza place it in the range between 1.4 and 1.6 (Bacaer and Ait Dads, 2011; Fraser et al., 2009; Munayco et al., 2009; Pourbohloul et al., 2009; Tuite et al., 2010; White et al., 2009; Yang et al., 2009), our approach accurately predicted the absence of a third wave of influenza in the US during the winter of 2010. We also used this scheme to accurately predict the second wave of pandemic influenza in London and the West Midlands, UK during the fall of 2009.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22325011      PMCID: PMC3703471          DOI: 10.1016/j.epidem.2011.11.003

Source DB:  PubMed          Journal:  Epidemics        ISSN: 1878-0067            Impact factor:   4.396


  31 in total

1.  The critical vaccination fraction for heterogeneous epidemic models.

Authors:  Andrew N Hill; Ira M Longini
Journal:  Math Biosci       Date:  2003-01       Impact factor: 2.144

2.  Genealogy with seasonality, the basic reproduction number, and the influenza pandemic.

Authors:  Nicolas Bacaër; El Hadi Ait Dads
Journal:  J Math Biol       Date:  2010-07-06       Impact factor: 2.259

3.  Survival of airborne influenza virus: effects of propagating host, relative humidity, and composition of spray fluids.

Authors:  F L Schaffer; M E Soergel; D C Straube
Journal:  Arch Virol       Date:  1976       Impact factor: 2.574

Review 4.  Study designs for evaluating different efficacy and effectiveness aspects of vaccines.

Authors:  M E Halloran; C J Struchiner; I M Longini
Journal:  Am J Epidemiol       Date:  1997-11-15       Impact factor: 4.897

5.  Estimated epidemiologic parameters and morbidity associated with pandemic H1N1 influenza.

Authors:  Ashleigh R Tuite; Amy L Greer; Michael Whelan; Anne-Luise Winter; Brenda Lee; Ping Yan; Jianhong Wu; Seyed Moghadas; David Buckeridge; Babak Pourbohloul; David N Fisman
Journal:  CMAJ       Date:  2009-12-03       Impact factor: 8.262

6.  Absolute humidity and the seasonal onset of influenza in the continental United States.

Authors:  Jeffrey Shaman; Virginia E Pitzer; Cécile Viboud; Bryan T Grenfell; Marc Lipsitch
Journal:  PLoS Biol       Date:  2010-02-23       Impact factor: 8.029

7.  Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study.

Authors:  Elizabeth Miller; Katja Hoschler; Pia Hardelid; Elaine Stanford; Nick Andrews; Maria Zambon
Journal:  Lancet       Date:  2010-01-21       Impact factor: 79.321

8.  The transmissibility and control of pandemic influenza A (H1N1) virus.

Authors:  Yang Yang; Jonathan D Sugimoto; M Elizabeth Halloran; Nicole E Basta; Dennis L Chao; Laura Matrajt; Gail Potter; Eben Kenah; Ira M Longini
Journal:  Science       Date:  2009-09-10       Impact factor: 47.728

9.  Mitigation measures for pandemic influenza in Italy: an individual based model considering different scenarios.

Authors:  Marta Luisa Ciofi degli Atti; Stefano Merler; Caterina Rizzo; Marco Ajelli; Marco Massari; Piero Manfredi; Cesare Furlanello; Gianpaolo Scalia Tomba; Mimmo Iannelli
Journal:  PLoS One       Date:  2008-03-12       Impact factor: 3.240

10.  Influenza virus transmission is dependent on relative humidity and temperature.

Authors:  Anice C Lowen; Samira Mubareka; John Steel; Peter Palese
Journal:  PLoS Pathog       Date:  2007-10-19       Impact factor: 6.823

View more
  11 in total

1.  Inferring the causes of the three waves of the 1918 influenza pandemic in England and Wales.

Authors:  Daihai He; Jonathan Dushoff; Troy Day; Junling Ma; David J D Earn
Journal:  Proc Biol Sci       Date:  2013-09-07       Impact factor: 5.349

2.  Too much of a good thing? When to stop catch-up vaccination.

Authors:  David W Hutton; Margaret L Brandeau
Journal:  Med Decis Making       Date:  2013-07-15       Impact factor: 2.583

3.  One versus two doses: What is the best use of vaccine in an influenza pandemic?

Authors:  Laura Matrajt; Tom Britton; M Elizabeth Halloran; Ira M Longini
Journal:  Epidemics       Date:  2015-06-22       Impact factor: 4.396

4.  Extrapolating theoretical efficacy of inactivated influenza A/H5N1 virus vaccine from human immunogenicity studies.

Authors:  Leora R Feldstein; Laura Matrajt; M Elizabeth Halloran; Wendy A Keitel; Ira M Longini
Journal:  Vaccine       Date:  2016-06-20       Impact factor: 3.641

5.  Differential Immune Profiles in Two Pandemic Influenza A(H1N1)pdm09 Virus Waves at Pandemic Epicenter.

Authors:  Lourdes Arriaga-Pizano; Eduardo Ferat-Osorio; Gabriela Rodríguez-Abrego; Ismael Mancilla-Herrera; Esteban Domínguez-Cerezo; Nuriban Valero-Pacheco; Marisol Pérez-Toledo; Fernando Lozano-Patiño; Fernando Laredo-Sánchez; José Malagón-Rangel; Haiko Nellen-Hummel; César González-Bonilla; Gabriel Arteaga-Troncoso; Arturo Cérbulo-Vázquez; Rodolfo Pastelin-Palacios; Paul Klenerman; Armando Isibasi; Constantino López-Macías
Journal:  Arch Med Res       Date:  2015-12-13       Impact factor: 2.235

6.  Epidemiological Impact of SARS-CoV-2 Vaccination: Mathematical Modeling Analyses.

Authors:  Monia Makhoul; Houssein H Ayoub; Hiam Chemaitelly; Shaheen Seedat; Ghina R Mumtaz; Sarah Al-Omari; Laith J Abu-Raddad
Journal:  Vaccines (Basel)       Date:  2020-11-09

7.  H3N2v and other influenza epidemic risk based on age-specific estimates of sero-protection and contact network interactions.

Authors:  Danuta M Skowronski; Flavia S Moser; Naveed Z Janjua; Bahman Davoudi; Krista M English; Dale Purych; Martin Petric; Babak Pourbohloul
Journal:  PLoS One       Date:  2013-01-11       Impact factor: 3.240

8.  Optimal vaccine allocation for the early mitigation of pandemic influenza.

Authors:  Laura Matrajt; M Elizabeth Halloran; Ira M Longini
Journal:  PLoS Comput Biol       Date:  2013-03-21       Impact factor: 4.475

9.  The impact of model building on the transmission dynamics under vaccination: observable (symptom-based) versus unobservable (contagiousness-dependent) approaches.

Authors:  Keisuke Ejima; Kazuyuki Aihara; Hiroshi Nishiura
Journal:  PLoS One       Date:  2013-04-12       Impact factor: 3.240

Review 10.  Pattern transitions in spatial epidemics: Mechanisms and emergent properties.

Authors:  Gui-Quan Sun; Marko Jusup; Zhen Jin; Yi Wang; Zhen Wang
Journal:  Phys Life Rev       Date:  2016-08-09       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.